top of page
Search
  • Writer's pictureARQon
    • Jun 28, 2019
    • 1 min read

Drugs - Jun 2019

  • China - CFDA Announcement No. 2017/187: Announcement on Cancellation of Drug Protection Fees, Certification Fees, Import / Export Licences Fees of Narcotic and Psychotropic Drugs

  • Philippines - FDA Circular No. 2012-007-A: Amending FDA Circular No. 2012-007: Reduction of Turn- Around-Time for the Regulatory Review of Clinical Trials and Revised Procedure for the Application of Import License for Investigational Products.

  • Singapore - Marketing Authorization Procedures: Procedure for Prescription Only to OTC Switch

  • Taiwan - MOHW Letter No.1081102318: Implementation of GDP on Pharmaceutical Products: Cold Chain Storage and Transportation - Supporting Measures.

Contact us at info@arqon.com.


25 views0 comments

Recent Posts

See All

Europe - May 2020

Denmark: New rules mean non-serious adverse events may also need to be reported EU: Application of Regulation (EU) 2017/745 postponed by one year EU: Continued use of lead as a thermal stabiliser in P

EU: MDR delayed to 26 May 2021

Application of the Medical Devices Regulation (MDR) has been deferred by one year, until 26 May 2021, for fear of shortage or delay in getting essential medical devices needed to combat Covid-19. The

bottom of page